Nelabin — Nelarabine
Nelarabine occupies a genuine niche in our oncology catalogue — it's one of only a handful of therapies specifically indicated for T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, cancers that are less common than their B-cell counterparts and correspondingly served by a smaller pool of global manufacturers, which makes reliable sourcing itself a meaningful differentiator when working with specialist hematology-oncology centers.
- Approved indications: T-cell acute lymphoblastic leukemia (T-ALL), T-cell lymphoblastic lymphoma (T-LBL), typically in patients who haven't responded to at least two prior chemotherapy regimens
- Mechanism: An antimetabolite that disrupts DNA synthesis specifically in T-lymphoblasts, halting cancer cell replication
- Storage advantage: Room-temperature stable (20–25°C) — unlike most oncology biologics, it requires no cold-chain logistics, a real cost advantage for distributors
- Buyer profile: Primarily specialist pediatric and adult hematology-oncology centers given the rarity of T-cell leukemia/lymphoma
Key Product Facts
250mg
Strength
Single-dose vial
Pack Size
Nelarabine
Active Ingredient
Oncology
Category
On Request
Availability
Nelarabine occupies a genuine niche in our oncology catalogue — it's one of only a handful of therapies specifically indicated for T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, cancers that are less common than their B-cell counterparts and correspondingly served by a smaller pool of global manufacturers, which makes reliable sourcing itself a meaningful differentiator when working with specialist hematology-oncology centers.
- Approved indications: T-cell acute lymphoblastic leukemia (T-ALL), T-cell lymphoblastic lymphoma (T-LBL), typically in patients who haven't responded to at least two prior chemotherapy regimens
- Mechanism: An antimetabolite that disrupts DNA synthesis specifically in T-lymphoblasts, halting cancer cell replication
- Storage advantage: Room-temperature stable (20–25°C) — unlike most oncology biologics, it requires no cold-chain logistics, a real cost advantage for distributors
- Buyer profile: Primarily specialist pediatric and adult hematology-oncology centers given the rarity of T-cell leukemia/lymphoma
- Neurological risk: Serious and potentially severe neurological effects, including seizures and cognitive impairment, are a significant known risk — requires close neurological monitoring throughout treatment
- Pregnancy/breastfeeding: Not recommended
- Hepatic/renal impairment: Requires dose adjustment and closer monitoring
- Myelosuppression: Regular blood count monitoring required, as with most antimetabolite chemotherapy
| Document |
Included |
| Certificate of Analysis (COA) |
? Standard |
| Certificate of Origin (COO) |
? Standard |
| MSDS |
? Standard |
Stock status: In stock for export | Quote turnaround: 24 hours
- Logistics: Standard export logistics — no cold chain required, a genuine cost advantage over biologics
- Coverage: Global, primarily specialist hematology-oncology centers
- Tracking: Full shipment tracking included
What is Nelarabine used for?
Treats T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Get Nelarabine price from a GMP-compliant Indian supplier — how?
Send strength and destination for a verified quote.
Does it require cold chain shipping?
No, it's stable at room temperature, unlike most oncology biologics.
Are there long-term side effects?
Neurological effects can occur and require close monitoring throughout treatment.
Who supplies Nelarabine from India?
WHO-GMP certified manufacturer with full export documentation.
